Dr. Irene Díaz-Moreno is Full Professor of Biochemistry and Molecular Biology at the Institute of Chemical Research of the Scientific Research Centre Isla de la Cartuja – cicCartuja, in Seville (Spain). She was awarded with her Ph.D. with European mention from the University of Seville in 2005. Dr. Irene Díaz-Moreno has worked in collaboration with groups at the Universities of Göteborg (Sweden) and Leiden (The Netherlands) on molecular recognition between metalloproteins involved in electron-transfer processes. She was an EMBO postdoctoral fellow (2006–2008) at the NIMR-MRC in London (UK), working on the regulatory mechanisms of mRNA decay by RNA-binding proteins. In 2010, she got a permanent position at the University of Seville, where she is developing research projects on Biointeractomics field, as well as on the post-translational regulation of biological macromolecules.

The FEBS Junior Section is organised by students and young researchers from some FEBS Constituent Societies. They develop joint activities, such as online talks and other events, and share resources, as well as open doors for young European scientists to opportunities outside their home countries by providing the relevant contacts and fostering communication within the network.

'FEBS Communications' posts general items from the FEBS Network Team as well as news on FEBS events and other activities.

The FEBS-IUBMB-ENABLE Conference is a joint initiative of FEBS, IUBMB, and several leading European biomedical research institutes (the ENABLE partners), building on a successful project originally funded by the EU Horizon 2020 Research and Innovation Programme (2017–2020). These interdisciplinary, international, three-day events are organized by and for young researchers in the molecular life sciences and attract up to 300 participants from around the world. Each conference features a scientific symposium, a career day, and outreach activities. ENABLE (the European Academy for Biomedical Science) was launched in 2017 through the collaboration of four renowned European institutes: the Institute for Research in Biomedicine (IRB Barcelona, Spain), the Novo Nordisk Foundation Center for Protein Research (NNF-CPR, Denmark), the Radboud Institute for Molecular Life Sciences at Radboudumc (Netherlands), and the European School of Molecular Medicine (SEMM, Italy). These core institutions hosted the first four conferences from 2017 to 2021. In 2022, FEBS and IUBMB joined forces with the ENABLE founders to relaunch the initiative as FEBS-IUBMB-ENABLE, expanding its reach and impact. In this new cycle, institutions can apply to become associated centres and host one of the events.